Literature DB >> 11512111

The effect of amitriptyline on pain intensity and perception of stress in bruxers.

A J Raigrodski1, S E Mohamed, D M Gardiner.   

Abstract

PURPOSE: The purpose of this clinical pilot study was to evaluate the effect of a tricyclic antidepressant, amitriptyline, on pain-intensity level and level of stress in bruxers.
MATERIALS AND METHODS: In a randomized, double-blind, crossover experimental design, 10 subjects received active (amitriptyline 25 mg/night) and inactive (placebo 25 mg/night) medication, over a period of 4 weeks.
RESULTS: The administration of amitriptyline for 4 weeks did not significantly (p >.05) reduce pain intensity. However, it significantly (p <.05) reduced the level of stress perception.
CONCLUSION: The results of this limited study do not support the administration of small doses of amitriptyline over a period of 4 weeks for the management of pain resulting from sleep bruxism. However, the results support the administration of small doses of amitriptyline for the management of the perception of stress levels associated with sleep bruxism. Copyright 2001 by The American College of Prosthodontists.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11512111     DOI: 10.1111/j.1532-849x.2001.00073.x

Source DB:  PubMed          Journal:  J Prosthodont        ISSN: 1059-941X            Impact factor:   2.752


  7 in total

1.  To see bruxism: a functional MRI study.

Authors:  S Yılmaz
Journal:  Dentomaxillofac Radiol       Date:  2015-03-25       Impact factor: 2.419

2.  Evaluation of Treatments in Patients with Nocturnal Bruxism on Bite Force and Occlusal Contact Area: A preliminary report.

Authors:  Alper Alkan; Emel Bulut; Selim Arici; Shuichi Sato
Journal:  Eur J Dent       Date:  2008-10

3.  Pain perception and functional/occlusal parameters in sleep bruxism subjects following a therapeutic intervention.

Authors:  Michelle Alicia Ommerborn; Rita Antonia Depprich; Christine Schneider; Maria Giraki; Matthias Franz; Wolfgang Hans-Michael Raab; Ralf Schäfer
Journal:  Head Face Med       Date:  2019-01-29       Impact factor: 2.151

4.  Consecutive Controlled Case Series on Effectiveness of Opipramol in Severe Sleep Bruxism Management-Preliminary Study on New Therapeutic Path.

Authors:  Mieszko Wieckiewicz; Helena Martynowicz; Tomasz Wieczorek; Anna Wojakowska; Katarzyna Sluzalec-Wieckiewicz; Pawel Gac; Rafal Poreba; Grzegorz Mazur; Efraim Winocur; Joanna Smardz
Journal:  Brain Sci       Date:  2021-01-22

5.  Evaluation of electromyographic signals in children with bruxism before and after therapy with Melissa Officinalis L-a randomized controlled clinical trial.

Authors:  Carolina Carvalho Bortoletto; Fernanda Cordeiro da Silva; Monica da Consolação Canuto Salgueiro; Lara Jansiski Motta; Lucia Maria Curiki; Raquel Agnelli Mesquita-Ferarri; Kristianne Porta Santos Fernandes; Sandra Kalil Bussadori
Journal:  J Phys Ther Sci       Date:  2016-03-31

6.  Comparison of amitriptyline with stabilization splint and placebo in chronic TMD patients: a pilot study.

Authors:  Iva Z Alajbeg; Ratka Boric Brakus; Ivan Brakus
Journal:  Acta Stomatol Croat       Date:  2018-06

7.  Origanum majorana Essential Oil Inhalation during Neurofeedback Training Reduces Saliva Myeloperoxidase Activity at Session-1 in Bruxistic Patients.

Authors:  José Joaquín Merino; José María Parmigiani-Izquierdo; María Elvira López-Oliva; María Eugenia Cabaña-Muñoz
Journal:  J Clin Med       Date:  2019-01-31       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.